Quantcast

Latest Acetylcholine Stories

76d0227ac22b20cead582d38c76b219f
2011-08-19 10:00:08

Researchers at the Faculty of Pharmaceutical Sciences at the University of Copenhagen have collaborated with the company NeuroSearch to generate new knowledge about an important part of the brain's complex communication system. The discovery could form the basis for future development of better medicines for patients with psychiatric disorders. The results were recently published Journal of Neuroscience. New knowledge challenges established scientific ideas about the function of the...

2011-08-16 08:00:00

ANNAPOLIS, Md., Aug. 16, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company has been awarded a $5.7 million contract under a Department of Defense (DoD) Broad Agency Announcement for studies directed at the development of an advanced expression system for the bioproduction of its nerve agent medical countermeasure program. rBChE is a recombinant form of a...

2011-08-15 12:07:33

New research led by scientists from Imperial College London explains why around half of people with asthma experience a 'late phase' of symptoms several hours after exposure to allergens. The findings, published in the journal Thorax, could lead to better treatments for the disease. An estimated 300 million people suffer from asthma, and the prevalence is rising. Symptoms are commonly triggered by allergens in the environment, such as pollen and dust mites. These stimuli can cause the airways...

2011-06-22 10:19:00

QUEBEC CITY, June 22, 2011 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin Driscoll will be presenting at the 2011 BIO Business Forum during the annual BIO International Convention. Mr. Driscoll's presentation will be given in the Georgetown Room of the Walter E. Washington Convention Center in Washington, DC on...

2011-05-16 14:21:04

Researchers in Baltimore have identified new compounds whichrelax airway muscles and may provide relief from shortness of breath for patients with COPD and asthma. The bitter-tasting compounds are at least as, if not more, effective than currently available agents used to manage these diseases, and may present new options for treatment. The study will be presented at the ATS 2011 International Conference in Denver. "We have identified compounds that are more potent than our previously...

2011-05-08 23:01:00

MADISON, Wis., May 9, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System (CNS) disorders, announces that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy (PSP). Orphan status entitles Mithridion to seven years of market exclusivity upon approval of MCD-386 for treating PSP, and...

2011-04-18 10:56:00

NEW YORK, April 18, 2011 /PRNewswire/ -- What: The MG Walk is a new signature fundraising campaign designed to provide hope for the thousands of families forced to face the challenges caused by myasthenia gravis. On Saturday, April 30th, The MG Walk comes to Greenfield Park in West Allis, Milwaukee County in order to raise funds and awareness for the MGFA! This effort will raise funds to help us continue our mission to provide programs to assist those living with MG and fund research, in...

2011-04-08 07:00:00

MINNETONKA, Minn., April 8, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI) announced that NHIC Corp., the Medicare carrier for Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont, will cover posterior tibial nerve stimulation (PTNS) using Uroplasty's Urgent® PC Neuromodulation System for the treatment of overactive bladder and associated symptoms, effective May 22, 2011. This decision adds approximately 1.8 million lives to those already covered...

2011-02-11 19:31:15

Newcastle University scientists have identified a new gene which will allow rapid diagnosis and earlier treatment of a debilitating neuromuscular condition. The gene, GFPT1, is crucial in causing a variation of Congenital Myasthenic Syndrome (CMS) which gained media attention recently with the plight of baby RB, who was at the centre of a "right-to-life" legal dispute. CMS is a rare genetic condition affecting the way signals travel between the brain and muscles which can cause paralysis and...

2011-01-24 15:34:18

Protection against nerve gas attack is a significant component of the defense system of many countries around the world. Nerve gases are used by armies and terrorist organizations, and constitute a threat to both the military and civilian populations, but existing drug solutions against them have limited efficiency. A multidisciplinary team of scientists at the Weizmann Institute of Science succeeded in developing an enzyme that breaks down such organophosphorus nerve agents efficiently...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related